Treatment of rheumatic diseases and hepatitis B virus coinfection

We often encounter rheumatological patients coinfected with hepatitis B in daily practice. In this paper, we will discuss the basic characteristics of the virus of hepatitis B, course of infection, the safety of rituximab, tocilizumab, abatacept treatment and therapeutic recommendations in managemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Felis-Giemza, Anna, Olesińska, Marzena, Świerkocka, Katarzyna, Więsik-Szewczyk, Ewa, Haładyj, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Review Article - Safety Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335127/
https://www.ncbi.nlm.nih.gov/pubmed/25549599
http://dx.doi.org/10.1007/s00296-014-3195-8
_version_ 1782358296120786944
author Felis-Giemza, Anna
Olesińska, Marzena
Świerkocka, Katarzyna
Więsik-Szewczyk, Ewa
Haładyj, Ewa
author_facet Felis-Giemza, Anna
Olesińska, Marzena
Świerkocka, Katarzyna
Więsik-Szewczyk, Ewa
Haładyj, Ewa
author_sort Felis-Giemza, Anna
collection PubMed
description We often encounter rheumatological patients coinfected with hepatitis B in daily practice. In this paper, we will discuss the basic characteristics of the virus of hepatitis B, course of infection, the safety of rituximab, tocilizumab, abatacept treatment and therapeutic recommendations in management of patients with rheumatic diseases.
format Online
Article
Text
id pubmed-4335127
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-43351272015-02-24 Treatment of rheumatic diseases and hepatitis B virus coinfection Felis-Giemza, Anna Olesińska, Marzena Świerkocka, Katarzyna Więsik-Szewczyk, Ewa Haładyj, Ewa Rheumatol Int Review Article - Safety Review We often encounter rheumatological patients coinfected with hepatitis B in daily practice. In this paper, we will discuss the basic characteristics of the virus of hepatitis B, course of infection, the safety of rituximab, tocilizumab, abatacept treatment and therapeutic recommendations in management of patients with rheumatic diseases. Springer Berlin Heidelberg 2014-12-31 2015 /pmc/articles/PMC4335127/ /pubmed/25549599 http://dx.doi.org/10.1007/s00296-014-3195-8 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review Article - Safety Review
Felis-Giemza, Anna
Olesińska, Marzena
Świerkocka, Katarzyna
Więsik-Szewczyk, Ewa
Haładyj, Ewa
Treatment of rheumatic diseases and hepatitis B virus coinfection
title Treatment of rheumatic diseases and hepatitis B virus coinfection
title_full Treatment of rheumatic diseases and hepatitis B virus coinfection
title_fullStr Treatment of rheumatic diseases and hepatitis B virus coinfection
title_full_unstemmed Treatment of rheumatic diseases and hepatitis B virus coinfection
title_short Treatment of rheumatic diseases and hepatitis B virus coinfection
title_sort treatment of rheumatic diseases and hepatitis b virus coinfection
topic Review Article - Safety Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335127/
https://www.ncbi.nlm.nih.gov/pubmed/25549599
http://dx.doi.org/10.1007/s00296-014-3195-8
work_keys_str_mv AT felisgiemzaanna treatmentofrheumaticdiseasesandhepatitisbviruscoinfection
AT olesinskamarzena treatmentofrheumaticdiseasesandhepatitisbviruscoinfection
AT swierkockakatarzyna treatmentofrheumaticdiseasesandhepatitisbviruscoinfection
AT wiesikszewczykewa treatmentofrheumaticdiseasesandhepatitisbviruscoinfection
AT haładyjewa treatmentofrheumaticdiseasesandhepatitisbviruscoinfection

Ejemplares similares